Multiparticulate controlled release selective serotonin...

Details Multiparticulate controlled release selective serotonin... Multiparticulate controlled release selective serotonin...

2000-05-10

2008-12-16

Tran, S. (Department: 1618)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S451000, C424S457000, C424S459000, C424S464000, C424S468000, C424S490000, C424S493000, C424S494000, C424S495000

Reexamination Certificate

active

07465462

ABSTRACT:
A multiparticulate controlled release selective serotonin reuptate inhibitor (SSRI) formulation for oral administration is provided. The formulation includes particles of an SSRI or a pharmaceutically acceptable salt thereof, which are coated with a rate-controlling polymer that allows controlled release of the SSRI over a period of not less than about 12 hours after oral administration. The rate controlling polymer includes a film-forming water-insoluble polymer, or a mixture of a film-forming water-insoluble polymer and a film-forming water-soluble polymer.

REFERENCES:
patent: 4085225 (1978-04-01), Welle et al.
patent: 4851228 (1989-07-01), Zentner et al.
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5271946 (1993-12-01), Hettche
patent: 5445829 (1995-08-01), Paradissis et al.
patent: 5776969 (1998-07-01), James
patent: 5948440 (1999-09-01), Arora et al.
patent: 5958458 (1999-09-01), Norling et al.
patent: 6066339 (2000-05-01), Stark et al.
patent: 6080736 (2000-06-01), Landry et al.
patent: 6183780 (2001-02-01), Van Balken et al.
patent: 6306436 (2001-10-01), Chungi et al.
patent: 6458384 (2002-10-01), Jaenicke et al.
patent: 6482440 (2002-11-01), Zemlan et al.
patent: 0 797 991 (1997-10-01), None
patent: 0 797 991 (1997-10-01), None
patent: 2 325 623 (1998-12-01), None
patent: 2 325 623 (1998-12-01), None
patent: 97 03670 (1997-02-01), None
patent: 99 01121 (1999-01-01), None
patent: 99 01122 (1999-01-01), None
patent: WO 9901122 (1999-01-01), None
patent: WO 9912524 (1999-03-01), None
Davidson, Jonathan et al, “Fluvoxamine-Controlled Release Formulation for the Treatment of Generalized Social Anxiety Disorder,” J. Clin. Psychopharmacol, vol. 24(2), pp. 118-125, Apr. 2004.
Westenberg, Herman et al , “A Double-Blind Placebo-Controlled Study of Controlled Release Fluvoxamine for the Treatment of Generalized Social Anxiety Disorder,” Journal of Clinical Psychopharmacology, vol. 24(1), pp. 49-55, Feb. 2004.
Hollander, Eric et al , “A Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder,” J. Clin. Psychiatry, 64:6, pp. 640-647, Jun. 2003.

Affiliated with

Also associated with

Rating

Multiparticulate controlled release selective serotonin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multiparticulate controlled release selective serotonin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multiparticulate controlled release selective serotonin... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4026653